Major Facilities |
George Breslauer |
UC Berkeley CIRM Center of Excellence |
$20,183,500 |
Research Training II |
Ellen Robey |
Interdisciplinary Training in Stem Cell Biology, Engineering and Medicine |
$6,888,557 |
Research Training Grant |
Dirk Hockemeyer |
Training the Next Generation of Biologists and Engineers for Regenerative Medicine |
$4,954,238 |
Research Leadership |
Xavier Darzacq |
Single Molecule Biophysics and Biology of Cellular Identity |
$4,175,924 |
COMPASS Training Grant |
John Matsui |
The COMPASS Scholars Program – Developing Today’s Untapped Talent into Tomorrow’s STEM Cell Researchers |
$2,908,950 |
Training Grant I-1 |
Randy Schekman |
Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland |
$2,360,457 |
New Faculty I |
Irina Conboy |
Identification of hESC-mediated molecular mechanism that positively regulates the regenerative capacity of post-natal tissues |
$2,246,020 |
Quest - Discovery Stage Research Projects |
Kevin Healy |
Novel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction |
$2,060,248 |
Quest - Discovery Stage Research Projects |
Fyodor Urnov |
A Treatment for Artemis-deficient Severe Combined Immunodeficiency using Non-Viral CRISPR-driven Safe Harbor Transgenesis in Hematopoietic Stem Cells |
$1,809,372 |
Shared Labs |
David Schaffer |
The Berkeley Human Embryonic Stem Cell Shared Research Laboratory |
$1,673,221 |
Quest - Discovery Stage Research Projects |
David Schaffer |
Scalable, Defined Production of Oligodendrocyte Precursor Cells to Treat Neural Disease and Injury |
$1,627,099 |
New Faculty II |
Lin He |
The roles of non-coding RNAs in the self-renewal and differentiation of pluripotent stem cells |
$1,406,823 |
Tools and Technologies II |
David Schaffer |
Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs |
$1,340,816 |
Tools and Technologies II |
Steven Conolly |
Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo |
$1,311,596 |
Tools and Technologies III |
David Schaffer |
Engineered Biomaterials for Scalable Manufacturing and High Viability Implantation of hPSC-Derived Cells to Treat Neurodegenerative Disease |
$1,239,276 |
Foundation - Discovery Stage Research Projects |
Michael Rape |
Control of OCT4 abundance and function in human stem cells |
$1,234,023 |
Shared Labs |
David Schaffer |
The Berkeley Human Embryonic Stem Cell Shared Research Laboratory |
$1,227,659 |
Basic Biology III |
Michael Rape |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,224,805 |
Basic Biology IV |
Robert Tjian |
Transcriptional regulation of pluripotency in human embryonic stem cells |
$1,220,968 |
Basic Biology III |
Song Li |
Induced Pluripotent Stem Cells for Tissue Regeneration |
$1,209,148 |
Basic Biology V |
Andrew Dillin |
A Requirement for Protein Homeostasis in the Mediation of Stem Cell Health |
$1,034,100 |
Transplantation Immunology |
Ellen Robey |
Human Immune System Mouse models as preclinical platforms for stem cell derived grafts |
$1,005,605 |
Transplantation Immunology |
David Raulet |
Inactivating NK cell reactivity to facilitate transplantation of stem cell derived tissue |
$952,896 |
Tools and Technologies I |
David Schaffer |
Directed Evolution of Novel AAV Variants for Enhanced Gene Targeting in Pluripotent Human Stem Cells and Investigation of Dopaminergic Neuron Differentiation |
$918,000 |
Quest - Discovery Stage Research Projects |
Kevin Healy |
Human Cardiac Chip for Assessment of Proarrhythmic Risk |
$899,581 |
Tools and Technologies I |
Steven Conolly |
Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner
for Tracking Stem Cells In Vivo |
$858,345 |
SEED Grant |
Ellen Robey |
In Vitro Differentiation of T cells from Human Embryonic Stem Cells. |
$477,894 |
SEED Grant |
Carolyn Bertozzi |
Profiling surface glycans and glycoprotein expression of human embryonic stem cells |
$444,847 |
Inception - Discovery Stage Research Projects |
Jacob Corn |
Genome editing for causation and reversion of MPN-associated mutations in human hematopoietic stem cells |
$235,800 |
Progression Award - Discovery Stage Research Projects |
Kevin Healy |
Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy |
$224,500 |
Conference II |
John Dueber |
BIC 2023 - 23rd Annual UC Systemwide Bioengineering Symposium |
$50,000 |
Conference |
Song Li |
University of California Systemwide Bioengineering Symposium 2012 |
$25,200 |